| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an osteogenesis enhancer comprising a molecule of acting on RANKL that enhances differentiation, maturation, or calcification of osteoblasts or cells capable of differentiating into osteoblasts. <P>SOLUTION: A pharmaceutical composition for treatment or prevention of metabolic bone diseases accompanied by the decrease in bone mass contains, as an active ingredient, a compound that acts on RANKL located on osteoblasts or cells capable of differentiating into osteoblasts and promotes differentiation, proliferation, maturation, or calcification of osteoblasts or cells capable of differentiating into osteoblasts. <P>COPYRIGHT: (C)2013,JPO&INPIT |
